Efficacy and Safety of Ravulizumab in Chinese Adults Participants With Generalized Myasthenia Gravis (gMG)
Clinical trial NCT07596784 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07596784
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-30
- Primary completion
- 2027-08-27
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.